BridgeBio to Unveil Long-Term Outcomes of Acoramidis Study at AHA 2024
Oct 4, 2024
Bridgebio Invest Advisor
BridgeBio's Infigratinib Granted FDA Breakthrough Therapy Designation for Achondroplasia Treatment
Sep 17, 2024
BridgeBio and CarDS Lab Collaborate on AI-Driven ATTR-CM Detection
Aug 27, 2024